Stay updated on ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Sign up to get notified when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The clinical trial record for the rheumatoid arthritis study is now displayed, including its terminated status, study design, eligibility, outcomes, and participant data-sharing information.
    Difference
    84%
    Check dated 2026-11-08T13:27:22.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The 403 message and Home button are gone, leaving the ClinicalTrials.gov page shell without visible study details. The site revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-11-01T14:30:19.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A banner was added announcing NIH website transition updates and noting that some NIH content may use “Super Intelligence” alongside “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T16:01:15.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changes from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:11:43.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T21:01:15.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with a generic error page. This renders the trial information inaccessible on this URL.
    Difference
    21%
    Check dated 2026-09-20T20:43:49.000Z thumbnail image

Stay in the know with updates to ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.